Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

LI-RADS

a great opportunity not to be missed

Renzulli, Matteoa; Clemente, Alfredoc; Brocchi, Stefanoa; Milandri, Matteoa; Lucidi, Vincenzoa; Vukotic, Rankab; Cappabianca, Salvatorec; Golfieri, Ritaa

European Journal of Gastroenterology & Hepatology: March 2019 - Volume 31 - Issue 3 - p 283–288
doi: 10.1097/MEG.0000000000001269
Review Articles

The Liver Imaging Reporting and Data System (LI-RADS) is a widespread comprehensive system for standardising the reporting and data collection of liver imaging to standardise chronic liver disease evaluation. However, the LI-RADS, based on the identification of some categories of lesions by means of a conceptual and nonquantitative probability approach, has many limitations. In fact, recently, the European Association for the Study of the Liver Guidelines regarding the management of hepatocellular carcinoma did not accept the LI-RADS. The aim of this paper was to critically analyse the LI-RADS, focusing on some interesting issues such as the absence of a clear distinction between two different imaging modalities (computed tomography and MRI), the lack of validation of some major features, the assessment of its ancillary features and its complexity. Despite these limitations, the LI-RADS represents a great opportunity for the radiological community. We must not let it escape, but time and experience are necessary for its improvement.

aRadiology Unit, Department of Diagnostic Medicine and Prevention, Sant’Orsola Hospital, University of Bologna

bDipartimento di Scienze Mediche e Chirurgiche, Centro di Ricerca per lo Studio delle Epatiti, Università degli Studi di Bologna, Bologna

cRadiology and Radiotherapy Unit, Department of Precision Medicine, University of Campania ‘L. Vanvitelli’, Naples, Italy

Correspondence to Matteo Renzulli, MD, Via Albertoni, 15, 40138 Bologna, Italy Tel: +39 051 214 2958; fax: +39 051 214 2699; e-mail: matteo.renzulli@aosp.bo.it

Received June 22, 2018

Accepted September 4, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.